23andMe Holding Co. (ME) Financials

ME Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 608.2 million 231.0 million
2023-09-30 801.2 million 176.0 million
2023-06-30 871.2 million 195.7 million
2023-03-31 942.6 million 228.7 million

ME Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -14.1 million 26.4 million
2023-09-30 -59.9 million 23.7 million
2023-06-30 -72.1 million 51.1 million
2023-03-31 -48.2 million 22.2 million

ME Net Income

No data available :(

ME Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 242.4 million - 78.8 million
2023-09-30 256.4 million - 81.0 million
2023-06-30 314.4 million - 83.2 million
2023-03-31 386.8 million - 85.3 million

ME Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 480.8 million
2023-09-30 474.9 million
2023-06-30 462.3 million
2023-03-31 456.3 million

ME Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 2.0 million 41.7 million 35.6 million 21.6 million
2023-09-30 2.8 million 54.6 million 29.9 million 11.0 million
2023-06-30 2.7 million 62.3 million 55.4 million 15.3 million
2023-03-31 3.3 million 60.7 million 26.8 million 21.8 million

ME Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 44.7 million 24.8 million
2023-09-30 50.0 million 28.3 million
2023-06-30 60.9 million 30.2 million
2023-03-31 92.4 million 52.4 million

ME

Price: $0.46

52 week price:
0.36
2.32

Earnings Per Share: -1.11 USD

P/E Ratio: -0.96

Exchange: NMS

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 1.6 million

Market Capitalization: 231.3 million

Links: